secwatch / observer
8-K filed March 24, 2023, 7:59 PM ET ticker BB CIK 0001070235
other material confidence high sentiment neutral materiality 0.70

BlackBerry sells ~32,000 non-core patents to Malikie for up to $900M; terminates prior Catapult deal

BLACKBERRY Ltd

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BLACKBERRY Ltd entered into Malikie Agreement with Malikie Innovations Limited valued at up to $900 million (effective 2023-03-20).

Action
entry
Agreement
asset purchase
Counterparty
Malikie Innovations Limited
Value
up to $900 million
Effective
2023-03-20
Exact text from the filing
On March 20, 2023, BlackBerry Limited (the “Company”) entered into an agreement to sell substantially all of its non-core patents and patent applications to Malikie Innovations Limited (“Malikie”), a newly-formed subsidiary of Key Patent Innovations Limited (“KPI”), a leading intellectual property monetization company, for a combination of cash at closing and potential future royalties in the aggregate amount of up to $900 million (the “Malikie Agreement”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BLACKBERRY Ltd terminated Catapult Agreement with Catapult IP Innovations Inc. (effective 2023-03-20).

Action
termination
Agreement
asset purchase
Counterparty
Catapult IP Innovations Inc.
Effective
2023-03-20
Exact text from the filing
Catapult was unable to secure financing that would have enabled it to complete the transaction on amended terms acceptable to the Company, and therefore the Company terminated the Catapult Agreement in accordance with its terms on March 20, 2023.
View on SEC.gov

Browse all material agreements →

BLACKBERRY Ltd filing history →

Source: SEC EDGAR
accession 0001070235-23-000047
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.